CA2087087A1 - Molecules pour administration par ionophorese - Google Patents

Molecules pour administration par ionophorese

Info

Publication number
CA2087087A1
CA2087087A1 CA2087087A CA2087087A CA2087087A1 CA 2087087 A1 CA2087087 A1 CA 2087087A1 CA 2087087 A CA2087087 A CA 2087087A CA 2087087 A CA2087087 A CA 2087087A CA 2087087 A1 CA2087087 A1 CA 2087087A1
Authority
CA
Canada
Prior art keywords
iontophoretic delivery
assemblages
amino acids
molecules
minus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2087087A
Other languages
English (en)
Other versions
CA2087087C (fr
Inventor
Burton H. Sage, Jr.
Randal A. Hoke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyteris Inc
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25239567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2087087(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of CA2087087A1 publication Critical patent/CA2087087A1/fr
Application granted granted Critical
Publication of CA2087087C publication Critical patent/CA2087087C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
CA002087087A 1992-01-22 1993-01-11 Molecules pour administration par ionophorese Expired - Fee Related CA2087087C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82373092A 1992-01-22 1992-01-22
US823,730 1992-01-22

Publications (2)

Publication Number Publication Date
CA2087087A1 true CA2087087A1 (fr) 1993-07-23
CA2087087C CA2087087C (fr) 2000-07-18

Family

ID=25239567

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087087A Expired - Fee Related CA2087087C (fr) 1992-01-22 1993-01-11 Molecules pour administration par ionophorese

Country Status (7)

Country Link
US (1) US5494679A (fr)
EP (1) EP0552878B2 (fr)
JP (1) JP2506543B2 (fr)
AU (1) AU665046B2 (fr)
CA (1) CA2087087C (fr)
DE (1) DE69323913T2 (fr)
ES (1) ES2130219T3 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
CA2087087C (fr) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules pour administration par ionophorese
GB9312351D0 (en) * 1993-06-16 1993-07-28 Ici Plc Thermal transfer printing dyesheet
US5843015A (en) * 1993-12-28 1998-12-01 Becton Dickinson And Company Molecules for iontophoretic delivery
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
WO1995028145A1 (fr) * 1994-04-18 1995-10-26 The Procter & Gamble Company Administration iontophoretique de bisphosphonates dans l'os alveolaire
IT1285405B1 (it) 1995-06-06 1998-06-03 Alza Corp Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
EP0920345A4 (fr) * 1996-06-19 2006-05-10 Vyteris Inc Administration iontophoretique d'inhibiteurs de l'adhesion cellulaire
AU746461B2 (en) 1997-05-14 2002-05-02 Aventis Pharmaceuticals Inc. Peptide parathyroid hormone analogs
EP0898962A1 (fr) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Emplâtres transdermiques et méthodes d'inactivation de protéases de la peau
DE69838485T2 (de) 1997-10-09 2008-06-26 Emory University Verfahren und vorrichtung zur transdermalen verabreichung von lithium
CN1278737A (zh) * 1997-11-12 2001-01-03 阿尔萨公司 减少多肽自结合的方法
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
CH696701A5 (de) * 2001-12-18 2007-10-15 Hoffmann La Roche Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen.
ES2473620T3 (es) 2007-02-06 2014-07-07 Hisamitsu Pharmaceutical Co., Inc. Dispositivo de microagujas para el diagnóstico de una alergia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5314072B2 (fr) * 1973-09-29 1978-05-15
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
JPS63102768A (ja) * 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4965343A (en) * 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
GB8806893D0 (en) * 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
EP0429842B1 (fr) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Dispositif d'administration transcutanée de médicaments à base de protéine ou de peptide
IT1244030B (it) * 1989-12-21 1994-06-28 Elan Corp Plc Dispostitivo in due parti per la somministrazione controllata di un ingrediente
JPH04224770A (ja) * 1990-12-26 1992-08-14 Teijin Ltd イオントフォレーシス用装置
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device
CA2087087C (fr) * 1992-01-22 2000-07-18 Burton H. Sage, Jr. Molecules pour administration par ionophorese

Also Published As

Publication number Publication date
AU3190593A (en) 1993-07-29
JP2506543B2 (ja) 1996-06-12
AU665046B2 (en) 1995-12-14
DE69323913T2 (de) 1999-10-14
EP0552878A2 (fr) 1993-07-28
EP0552878B2 (fr) 2002-11-20
DE69323913D1 (de) 1999-04-22
CA2087087C (fr) 2000-07-18
US5494679A (en) 1996-02-27
JPH05345727A (ja) 1993-12-27
EP0552878B1 (fr) 1999-03-17
EP0552878A3 (en) 1993-08-25
ES2130219T3 (es) 1999-07-01

Similar Documents

Publication Publication Date Title
CA2087087A1 (fr) Molecules pour administration par ionophorese
US5654451B1 (en) Amino acids and peptides having modified c-terminals and modified n-terminals
IE800694L (en) Enzymatic producion of peptides.
WO1997021815A3 (fr) Proteines antifongiques
AU9174398A (en) Peptides
CA2071875A1 (fr) Derive du facteur viii recombinant humain
CA2191950A1 (fr) Peptides marques au technetium-99m pour l'imagerie
CA2079584A1 (fr) Methodes de trans-destabilisation in vivo de proteines specifiques
CA2094027A1 (fr) Peptides osteogenes
EP0304279A3 (fr) Déterminant peptidique associé à l'immunité
WO1996028470A3 (fr) Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques
AU4415796A (en) Production of c-terminal amidated peptides from recombinant protein constructs
CA2249180A1 (fr) Procedes de production microbienne recombinante de proteines de fusion bpi et de peptides derives de bpi
EP0875567A3 (fr) Protéines à doigts de zinc se liant à l'oncogène mycm ainsi comment leur préparation et utilisation
AU5090898A (en) Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
AU4120096A (en) Production of recombinant peptides as natural hydrophobic peptide analogues
CA2021722A1 (fr) Proteines variantes et polypeptides ayant plus d'affinite pour les matrices d'affinite immobilisees
AU7662387A (en) Novel substrate peptides
WO1999002708A8 (fr) Proteines de fusion comprenant des structures bispiralees derivees de la proteine inhibitrice de if1 atpase bovine
CA2259640A1 (fr) Vecteur de glycine humaine
AU7254891A (en) Renin inhibiting peptides having an alpha-heteroatom amino acid at the p3 position
AU3524993A (en) Method of peptide synthesis and new synthesis intermediates
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
NZ335136A (en) Isolated peptides which complex with hla-cw*16 molecules, and uses thereof
NZ511747A (en) Regulatory/unfolding peptides of ezrin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed